Cellectar Biosciences Inc (CLRB)

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Cellectar Biosciences Inc

(608) 441-8120

100 CAMPUS DRIVE, FLORHAM PARK, NJ

Prossima data di guadagno

Ultimi documenti SEC

CLRB's Discussions on Twitter

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-07-01	Iniziato	Oppenheimer	Outperform
2020-01-21	Ripresa	ROTH Capital	Buy
2019-09-13	Iniziato	ROTH Capital	Buy
2016-12-21	Iniziato	Ladenburg Thalmann	Buy

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Cellectar Biosciences Inc (CLRB)

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

Cellectar Biosciences Inc Borsa (CLRB) Ultime notizie

Cellectar Biosciences (NASDAQ:CLRB) Stock Quotes, Forecast and News Summary - Benzinga

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below 200 Day Moving Average of $2.99 - Defense World

Cellectar Biosciences (NASDAQ:CLRB) Stock Price Passes Below 200 Day Moving Average of $2.99 - MarketBeat

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Short Interest Update - MarketBeat

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - MSN

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - Zacks Investment Research

Cellectar Biosciences to Present at IWWM Featuring Iopofosine I 131 - Yahoo Finance

Iopofosine I 131 Featured in Two Separate Presentations at - GlobeNewswire

Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia - StockTitan

Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements - MSN

Cellectar to Restate Previously Issued Financial Statements - GlobeNewswire

Cellectar to Restate Previously Issued Financial Statements – Company Announces Receipt of Expected Delinquency Notification Letter from Nasdaq - StockTitan

Neuroblastoma Drugs Market to Witness Huge Growth by 2031 - openPR

Vanguard Group Inc. Buys 708,191 Shares of Cellectar Biosciences, Inc. (NASDAQ:CLRB) - MarketBeat

Vanguard Group Inc. Has $4.74 Million Holdings in Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Defense World

Equities Analysts Set Expectations for Cellectar Biosciences, Inc.’s Q3 2024 Earnings (NASDAQ:CLRB) - Defense World

Equities Analysts Set Expectations for Cellectar Biosciences, Inc.'s Q3 2024 Earnings (NASDAQ:CLRB) - MarketBeat

FY2027 Earnings Forecast for Cellectar Biosciences, Inc. Issued By Roth Capital (NASDAQ:CLRB) - Defense World

FY2027 Earnings Estimate for Cellectar Biosciences, Inc. Issued By Roth Capital (NASDAQ:CLRB) - MarketBeat

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Cellectar Biosciences reports strong trial results for iopofosine By Investing.com - Investing.com Canada

Earnings call: Cellectar Biosciences reports strong trial results for iopofosine - Investing.com

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - GlobeNewswire

CLRBCellectar Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Cellectar Biosciences sees cash balance sufficient into 2Q25 - TipRanks

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - StockTitan

Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update - Yahoo Finance

Here's Why You Should Retain Accuray (ARAY) Stock for Now - Zacks Investment Research

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday - Defense World

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday - MarketBeat

UPDATE -- Cellectar Biosciences to Announce Second Quarter - GlobeNewswire

UPDATE — Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - ForexTV.com

UPDATE -- Cellectar Biosciences to Announce Second Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - StockTitan

Cellectar Biosciences to Announce First Quarter Financial - GlobeNewswire

Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, August 13, 2024 - StockTitan

We Think Cellectar Biosciences (NASDAQ:CLRB) Needs To Drive Business Growth Carefully - Simply Wall St

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below Two Hundred Day Moving Average of $3.23 - Defense World

Cellectar Biosciences (NASDAQ:CLRB) Stock Passes Below Two Hundred Day Moving Average of $3.23 - MarketBeat

CLRB (Cellectar Biosciences) GF Value : $0.00 (As of Aug. 07, 2024) - GuruFocus.com

It is Poised to be a Bull Market for Cellectar Biosciences Inc (CLRB) - SETE News

Insider’s View: Deciphering Cellectar Biosciences Inc (CLRB)’s Financial Health Through Ratios - The Dwinnex

Top investors say Cellectar Biosciences Inc (CLRB) ticks everything they need - SETE News

The Psychology of Cellectar Biosciences Inc Inc. (CLRB) Price Performance: Understanding Market Sentiment - The InvestChronicle

Was Cellectar Biosciences Inc (CLRB)’s session last reading good? - US Post News

Balance Sheet Breakdown: Cellectar Biosciences Inc (CLRB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Bone Cancer Drugs Market is expected to reach US$ 1,830.6 Mn with - openPR

Roth Capital Comments on Cellectar Biosciences, Inc.'s FY2026 Earnings (NASDAQ:CLRB) - MarketBeat

Research Analysts Offer Predictions for Cellectar Biosciences, Inc.’s FY2026 Earnings (NASDAQ:CLRB) - Defense World

FY2028 EPS Estimates for Cellectar Biosciences, Inc. Cut by Analyst (NASDAQ:CLRB) - American Banking and Market News

FY2028 EPS Estimates for Cellectar Biosciences, Inc. Cut by Analyst (NASDAQ:CLRB) - Defense World

Analysts Set Expectations for TransAlta Co.’s Q2 2024 Earnings (TSE:TA) - Defense World

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a CLRB